Drug Information

Drug General Information
Drug ID
D04YWM
Former ID
DCL000706
Drug Name
Atacicept
Indication Lymphoma; Graft rejection in heart transplantation; Idiopathic thrombocytopenic purpura [ICD9: 202.8, 208.9, 287.31, 996; ICD10:C81-C86, D69.3, T86] Phase 3 [530405], [537129]
Rheumatold arthritis; Multiple sclerosis [ICD9: 340, 710-719, 714; ICD10:G35, M00-M25, M05-M06] Phase 2 [537129]
Company
ZymoGenetics; Serono
CAS Number
CAS 845264-92-8
Target and Pathway
Target(s) APRIL Target Info Modulator [530405]
References
Ref 530405Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis. Nervenarzt. 2009 Dec;80(12):1462-72.
Ref 537129New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21.
Ref 530405Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis. Nervenarzt. 2009 Dec;80(12):1462-72.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.